Dimerix Limited (ASX:DXB)
Australia flag Australia · Delayed Price · Currency is AUD
0.5100
-0.0100 (-1.92%)
Sep 26, 2025, 4:12 PM AEST

Dimerix Company Description

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology.

The company is headquartered in Fitzroy, Australia.

Dimerix Limited
Dimerix logo
CountryAustralia
IndustryBiotechnology
SectorHealthcare
CEONina Webster

Contact Details

Address:
425 Smith Street
Fitzroy, 3065
Australia
Phone1300 813 321
Websitedimerix.com

Stock Details

Ticker SymbolDXB
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU000000DXB7
SIC Code2836

Key Executives

NamePosition
Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, MBA, Ph.D.Chief Executive Officer, MD and Director
Robert ShepherdChief Operating Officer
Dr. David Everett Fuller BPharm, M.D., MBBSChief Medical Officer
Hamish George B.Com., C.A.Chief Financial Officer and Company Secretary
Kevin Donald George Pfleger BA (Hons), MA, Ph.D.Chief Scientific Advisor